Paolo Tombesi Turning Point Therapeutics, Inc. (TPTX) insider trading activity

TPTX Quotes by TradingView

Paolo Tombesi is EVP & Chief Financial Officer of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2022, when has been sold 29,778 shares (Common Stock) at a price of $76.0 per share, resulting in proceeds of $2,263,128. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

PAOLO TOMBESI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2022
SELL
Sale (or disposition) back to the issuer
$2,263,128 $76.0 p/Share
29,778 Reduced 100.0%
0 Common Stock
Jul 27 2022
SELL
Open market or private sale
$88,654 $74.94 p/Share
1,183 Reduced 3.96%
28,700 Common Stock
Feb 09 2022
BUY
Grant, award, or other acquisition
-
16,283 Added 35.27%
29,883 Common Stock
Jul 26 2021
BUY
Grant, award, or other acquisition
-
13,600 Added 50.0%
13,600 Common Stock

Also insider at

EPZM
Epizyme, Inc. Healthcare
Chief Financial Officer
PT

Paolo Tombesi

EVP & Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPTX